Search Results
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital/ University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by S C Clement in
Google Scholar
PubMed
Search for other papers by W E Visser in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by C A Lebbink in
Google Scholar
PubMed
Search for other papers by D Albano in
Google Scholar
PubMed
Search for other papers by H L Claahsen-van der Grinten in
Google Scholar
PubMed
Search for other papers by A Czarniecka in
Google Scholar
PubMed
Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Search for other papers by R P Dias in
Google Scholar
PubMed
Search for other papers by M P Dierselhuis in
Google Scholar
PubMed
Search for other papers by I Dzivite-Krisane in
Google Scholar
PubMed
Search for other papers by R Elisei in
Google Scholar
PubMed
Search for other papers by A Garcia-Burillo in
Google Scholar
PubMed
Search for other papers by L Izatt in
Google Scholar
PubMed
Search for other papers by C Kanaka-Gantenbein in
Google Scholar
PubMed
Search for other papers by H Krude in
Google Scholar
PubMed
Search for other papers by L Lamartina in
Google Scholar
PubMed
Search for other papers by K Lorenz in
Google Scholar
PubMed
Search for other papers by M Luster in
Google Scholar
PubMed
Search for other papers by R Navardauskaitė in
Google Scholar
PubMed
Search for other papers by M Negre Busó in
Google Scholar
PubMed
Search for other papers by K Newbold in
Google Scholar
PubMed
Search for other papers by R P Peeters in
Google Scholar
PubMed
Search for other papers by G Pellegriti in
Google Scholar
PubMed
Search for other papers by A Piccardo in
Google Scholar
PubMed
Search for other papers by A L Priego in
Google Scholar
PubMed
Search for other papers by A Redlich in
Google Scholar
PubMed
Search for other papers by L de Sanctis in
Google Scholar
PubMed
Search for other papers by M Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by A S P van Trotsenburg in
Google Scholar
PubMed
Search for other papers by F A Verburg in
Google Scholar
PubMed
Search for other papers by M Vriens in
Google Scholar
PubMed
Search for other papers by T P Links in
Google Scholar
PubMed
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK
Office for Rare Conditions, University of Glasgow, Glasgow, UK
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by H M van Santen in
Google Scholar
PubMed
Background Pediatric differentiated thyroid carcinoma (DTC) is a rare disease, although it is the most frequent endocrine malignancy in children, representing 2–4% of all pediatric malignancies. According to the Surveillance, Epidemiology, and
Search for other papers by C Sui in
Google Scholar
PubMed
Search for other papers by Q He in
Google Scholar
PubMed
Search for other papers by R Du in
Google Scholar
PubMed
Search for other papers by D Zhang in
Google Scholar
PubMed
Search for other papers by F Li in
Google Scholar
PubMed
Search for other papers by G Dionigi in
Google Scholar
PubMed
Search for other papers by N Liang in
Google Scholar
PubMed
Search for other papers by H Sun in
Google Scholar
PubMed
node ratio in well-differentiated thyroid carcinoma . American Surgeon 2010 76 28 – 32 . 8 Wu MH Shen WT Gosnell J Duh QY . Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer
Search for other papers by Alexander Heinzel in
Google Scholar
PubMed
Search for other papers by Dirk Müller in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Emma Children’s Hospital, Amsterdam UMC, Department of Pediatrics, Amsterdam, The Netherlands
Search for other papers by Sarah C Clement in
Google Scholar
PubMed
Search for other papers by Arthur B Schneider in
Google Scholar
PubMed
University Hospital Würzburg, Department of Nuclear Medicine, Würzburg, Germany
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
-1375678 ) 13 Thies ED Tanase K Maeder U Luster M Buck AK Hanscheid H Reiners C Verburg FA . The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma
Search for other papers by Simonetta Piana in
Google Scholar
PubMed
Search for other papers by Eleonora Zanetti in
Google Scholar
PubMed
Search for other papers by Alessandra Bisagni in
Google Scholar
PubMed
Search for other papers by Alessia Ciarrocchi in
Google Scholar
PubMed
Search for other papers by Davide Giordano in
Google Scholar
PubMed
Search for other papers by Federica Torricelli in
Google Scholar
PubMed
Search for other papers by Teresa Rossi in
Google Scholar
PubMed
Search for other papers by Moira Ragazzi in
Google Scholar
PubMed
mediates growth suppression by cell cycle arrest in well-differentiated thyroid carcinomas (WDTCs) ( 15 , 16 ). On the other side, NOTCH1 has been described highly expressed in WDTC with BRAF , RET /papillary thyroid carcinoma (PTC) mutation or active
Search for other papers by Meihua Jin in
Google Scholar
PubMed
Search for other papers by Woo Kyung Lee in
Google Scholar
PubMed
Search for other papers by Mi-Hyeon You in
Google Scholar
PubMed
Search for other papers by Ahreum Jang in
Google Scholar
PubMed
Search for other papers by Sheue-yann Cheng in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Yu-Mi Lee in
Google Scholar
PubMed
, anaplastic thyroid carcinoma. SHMT2 is associated with de-differentiation and stemness of thyroid cancer To validate the clinical importance of the SHMT2 in human thyroid cancer, we performed a comprehensive analysis using transcriptomes and
Search for other papers by David C Llewellyn in
Google Scholar
PubMed
Faculty of Life Sciences and Medicine, Kings College London, London, UK
Search for other papers by Rajaventhan Srirajaskanthan in
Google Scholar
PubMed
Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK
Search for other papers by Royce P Vincent in
Google Scholar
PubMed
Search for other papers by Catherine Guy in
Google Scholar
PubMed
Search for other papers by Eftychia E Drakou in
Google Scholar
PubMed
Neuroendocrine Tumour Unit, Kings Health Partners ENETS Centre of Excellence, Denmark Hill, London, UK
Search for other papers by Simon J B Aylwin in
Google Scholar
PubMed
Barts and the London School of Medicine, Centre for Endocrinology, William Harvey Institute, London, UK
Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Faculty of Life Sciences and Medicine, Kings College London, London, UK
Search for other papers by John K Ramage in
Google Scholar
PubMed
Faculty of Life Sciences and Medicine, School of Life Course Sciences, Obesity Immunometabolism and Diabetes Group, King’s College London, London, UK
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
, Napsin A, thyroglobulin and p40 was negative ( Fig. 4C ). The Ki-67 proliferation index was high at 84%. The morphology and immunophenotype were most in keeping with metastatic medullary thyroid carcinoma, although other metastatic neuroendocrine
Search for other papers by Olav Inge Håskjold in
Google Scholar
PubMed
Search for other papers by Henrik Stenestø Foshaug in
Google Scholar
PubMed
Search for other papers by Therese Benedikte Iversen in
Google Scholar
PubMed
Search for other papers by Helga Charlotte Kjøren in
Google Scholar
PubMed
UiT – The Arctic University of Norway, Institute of Clinical Medicine
Search for other papers by Vegard Heimly Brun in
Google Scholar
PubMed
: colloid nodule, adenomatoid colloid nodule, follicular adenoma, follicular carcinoma, follicular variant of papillary thyroid carcinoma, papillary thyroid carcinoma, or other thyroid cancer. The operator also indicated the confidence of the assignment to
Search for other papers by Tiemo S Gerber in
Google Scholar
PubMed
Search for other papers by Arno Schad in
Google Scholar
PubMed
Search for other papers by Nils Hartmann in
Google Scholar
PubMed
Search for other papers by Erik Springer in
Google Scholar
PubMed
Search for other papers by Ulrich Zechner in
Google Scholar
PubMed
Search for other papers by Thomas J Musholt in
Google Scholar
PubMed
Introduction Poorly differentiated thyroid carcinoma (PDTC) represents an aggressive variant of thyroid cancer that predominantly arises from the differentiated variants of papillary and follicular thyroid carcinoma (PTC and FTC, respectively
Search for other papers by Luchuan Li in
Google Scholar
PubMed
Search for other papers by Baoyuan Li in
Google Scholar
PubMed
Search for other papers by Bin Lv in
Google Scholar
PubMed
Search for other papers by Weili Liang in
Google Scholar
PubMed
Search for other papers by Binbin Zhang in
Google Scholar
PubMed
Search for other papers by Qingdong Zeng in
Google Scholar
PubMed
Search for other papers by Andrew G Turner in
Google Scholar
PubMed
Search for other papers by Lei Sheng in
Google Scholar
PubMed
, all were assessed to be well-differentiated papillary thyroid carcinoma (PTC), namely 21 cases (81%) of papillary thyroid microcarcinoma (PTMC), 3 cases (12%) of conventional PTC, and 2 cases (7%) of a tall-cell variant of PTC ( Table 3 ). Bilaterality
Search for other papers by Andrea Mazurat in
Google Scholar
PubMed
Search for other papers by Andrea Torroni in
Google Scholar
PubMed
Search for other papers by Jane Hendrickson-Rebizant in
Google Scholar
PubMed
Search for other papers by Harbinder Benning in
Google Scholar
PubMed
Search for other papers by Richard W Nason in
Google Scholar
PubMed
Search for other papers by K Alok Pathak in
Google Scholar
PubMed
Introduction Well-differentiated thyroid carcinoma (WDTC) represents a group of thyroid cancers that are associated with increasing incidence and excellent posttreatment outcome (1) . This group comprises different histological types, the most